NewsBite

Nucleus Network’s world-class Geelong facility recruits for human clinical trials

Australia’s largest clinical trials provider will host groundbreaking medical research into such diseases as multiple sclerosis with recruitment open at its new Geelong facility.

Michael J. Fox reveals ‘tough’ toll his Parkinson’s battle has on his family

Geelong is set to host human clinical trials for groundbreaking medical research and to speed up the development of new treatments, with a new facility in the city.

Medical Research Minister Jaala Pulford welcomed confirmation Australia’s largest clinical trials provider, Nucleus Network, had opened its first satellite clinic and was recruiting trial participants in Geelong.

Established in 2004 by Baker IDI Heart and Diabetes Institute, with an $8m Victorian government investment, Nucleus Network has grown to become a highly successful company with global impact.

Medical Research Minister <i/>Jaala Pulford hails news Nucleus Network has opened its first satellite clinic and is recruiting trial participants in Geelong. Picture: NCA NewsWire
Medical Research Minister Jaala Pulford hails news Nucleus Network has opened its first satellite clinic and is recruiting trial participants in Geelong. Picture: NCA NewsWire

The Geelong world-class clinical trial facility, located on Ryrie St, will give residents the opportunity to attend appointments locally to determine their eligibility for a study, as well as ­allowing convenient post-study visits.

The clinic is conducting trials including a treatment for central nervous system diseases such as multiple sclerosis and CNS lymphoma, and a potential new treatment for non-cystic fibrosis bronchiectasis.

Nucleus Network also has facilities in Melbourne, Brisbane and Minneapolis in the US, and runs clinical trials for some of the biggest pharmaceutical companies in the world including US-based biotechnology company, Novavax, for which it ran Covid vaccine trials in Australia earlier this year.

Clinical trials held in Victoria contribute more than $300m annually to the state’s economy.
Clinical trials held in Victoria contribute more than $300m annually to the state’s economy.

Clinical trials held in Victoria contribute more than $300m annually to the state’s economy.

“Clinical trials are critically important for patients and the opening of this new facility in Geelong is boosting ­Victoria’s reputation as a sought-after location for medical research,” Ms ­Pulford said.

Nucleus Network chief operating officer Charlotte Hall said through the new satellite clinic, it would be able to reach even more people and cement its position as a key partner to some of the industry’s largest and most respected clients in the sector, which was great for Australia and Victoria.

Originally published as Nucleus Network’s world-class Geelong facility recruits for human clinical trials

Add your comment to this story

To join the conversation, please Don't have an account? Register

Join the conversation, you are commenting as Logout

Original URL: https://www.themercury.com.au/news/geelong/nucleus-networks-worldclass-geelong-facility-recruits-for-human-clinical-trials/news-story/8509a08cb2693e0087621e0efcbb6679